Details of the Drug

General Information of Drug (ID: DMX0C5Z)

Drug Name

APL-130277

Synonyms

Apomorphine hydrochloride hemihydrate; UNII-F39049Y068; Apmorphine hydrochloride hemihydrate; Apomorphin hydrochlorid wasser (2/1); Apomorphine hydrochloride [USP]; 6abeta-Aporphine-10,11-diol hydrochloride hemihydrate; Apomorphine hydrochloride hydrate; F39049Y068; Uprima (TN); DSSTox_RID_82721; DSSTox_CID_28159; DSSTox_GSID_48185; Apomorphine hydrochloride (USP); 58-00-4 (Parent); CHEBI:31228; 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, hydrate

Indication

Disease Entry	ICD 11	Status	REF
Epilepsy	8A60-8A68	Phase 3	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C34H38Cl2N2O5
Canonical SMILES: CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.O.Cl.Cl
InChI: 1S/2C17H17NO2.2ClH.H2O/c2*1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;;;/h2*2-6,13,19-20H,7-9H2,1H3;2*1H;1H2/t2*13-;;;/m11.../s1
InChIKey: CXWQXGNFZLHLHQ-DPFCLETOSA-N

Cross-matching ID

PubChem CID: 107882
ChEBI ID: CHEBI:31228
CAS Number: 41372-20-7
TTD ID: D01KYP

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)